PRKN and Parkinson disease: c-Abl activation could contribute to the neurodegeneration in PD through several different pathways including tyrosine phosphorylation of parkin leading to impaired parkin function and tyrosine phosphorylation of α-synuclein leading to enhanced α-synuclein aggregation (11,13).